Background: Maternal allergy and gestational exposures can alter the concentration of type-1/type-2/T-regulatory markers in breast milk. We tested whether maternal risk factors are related to breast milk immune markers. Methods: Expecting mothers were enrolled in [2008][2009][2010] in South Carolina in prenatal clinics and classes. Interferon (IFN)-γ-induced protein 10 (CXCL10), CCL11, interleukin (IL)-1β, IL-4, IL-5, IL-6, CXCL8, IL-10, IL-12(p70), IL-13, transforming growth factor (TGF)-β1, and immunoglobulin (Ig)A in 115 whey samples were measured by immunoassays. Maternal asthma, eczema, rhinitis, smoking, urogenital infections during gestation, pet exposure, education, race/ethnicity, age, body mass, and the child's birth date and sex were ascertained. The effects of these risk factors on immune markers were estimated using general linear models. results: Maternal asthma was linked to higher levels of IL-5, rhinitis to lower levels of IL-5 and INF-γ, and eczema to lower levels of IL-6. Gestational smoking was related to increased concentrations of CXCL8 and IL-6. African-American mothers had markedly higher levels of IL-6, IFN-γ, and CXCL8. Urogenital infections, maternal age, body mass, child's sex, and season of birth contributed to the variation. conclusion: The impact of maternal allergies on immune markers in breast milk was small compared with that of maternal nondisease characteristics. t he prevalence of allergic diseases, including asthma, eczema, and rhinitis, has increased significantly in past decades. Studies have reported that breastfeeding may influence the development of atopic disease (1-3). Breast milk contains a large number of immune-modulating factors (e.g., cytokines, chemokines, immunoglobulins (Ig), enzymes, and hormones) that are thought not only to allow the development of the infant's immune system but also to protect the infant from infection and gut inflammation (2,4,5). Because cytokines and chemokines are significant immune-modulating agents found in breast milk, identification of factors that influence their levels in breast milk is of importance. Knowledge on breast milk immune markers will help to evaluate future disease risks of breastfed infants.Several studies have reported different concentrations of immune constituents in breast milk obtained from atopic vs. nonatopic mothers (2,4,6,7), in addition to that obtained from mothers whose children developed cow's milk allergies compared with mothers having nonallergic children (3,5). Hence, exposures to different levels of immune factors through breast milk are considered to affect the occurrence of childhood allergies. However, relatively few studies have examined factors (e.g., maternal allergy) that may alter breast milk cytokine/ chemokine and IgA levels (2,4,5,8,9). Circumstantial evidence suggests that maternal allergy may be an important factor because a history of maternal asthma, rhinitis, and eczema seems to increase the risk of allergic diseases in infants (10). Studies have reported that mothers with allergic di...